In an impressive display of market confidence and continued innovation, Dollar Shave Club has successfully raised $1 billion in its latest funding round. Founded in 2011, Dollar Shave Club burst onto the scene with a viral marketing campaign that not only disrupted the shaving industry but also established a new standard in humorous advertising. By introducing a direct-to-consumer model, the company effectively dismantled outdated conventions upheld by industry giants, positioning itself as an irreverent and bold force in men’s grooming. Beyond providing high-quality razors at an affordable price, Dollar Shave Club has expanded its offerings to include an array of creatively designed, problem-solving products such as Ball Spray, addressing unique needs that many men didn't even know existed. The newly acquired funds will be pivotal in accelerating the company’s international growth ambitions and expanding its already robust line of grooming products. As Dollar Shave Club continues its mission to make personal care more approachable and enjoyable, this funding will enable the team to enhance product development, sustain its disruptive DNA, and amplify its presence in thousands of retail locations across the globe. With a clear vision for the future and an unwavering commitment to humor, innovation, and customer satisfaction, Dollar Shave Club is primed to make the hairy world a little smoother—and invites everyone to join the club. Stop wasting time and learn more at Dlrshv.es/WelcomeToTheClub!
Shaving Giants Beware: Dollar Shave Club Secures $1 Billion Funding to Revolutionize Grooming Industry!
Get the full Dollar Shave Club company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today